Submitted by Anonymous (not verified) on 9 October 2023 - 13:07
Human medicines European public assessment report (EPAR): Bortezomib Hospira, bortezomib, Multiple Myeloma, Date of authorisation: 22/07/2016, Revision: 13, Status: Authorised
Source: